The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Clinical trial NCT03192644 · UNKNOWN
Trial details
- NCT number
- NCT03192644
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2022-12-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.